Author:
Rnjak D.,Ravlić S.,Šola A.-M.,Halassy B.,Šemnički J.,Šuperba M.,Hećimović A.,Kurolt I.-C.,Kurtović T.,Mačak Šafranko Ž.,Polančec D.,Bendelja K.,Mušlin T.,Jukić I.,Vuk T.,Zenić L.,Artuković M.
Funder
European Regional Development Fund
Croatian Science Foundation
Subject
Biochemistry, medical,Clinical Biochemistry,Hematology
Reference38 articles.
1. Author correction: a new coronavirus associated with human respiratory disease in China;Wu;Nature [Internet],2020
2. Coronavirus Disease 2019 (COVID19) Treatment Guidlines. National Instututes of Health. Available at https://www.covid19treatmentguidelines.nih.gov/. Accessed 28.02.2021. Coronavirus Disease 2019 (COVID19) Treatment Guidlines. National Instututes of Health. Available at https://www.covid19treatmentguidelines.nih.gov/. Accessed.[28.02.2021.].
3. Three patients with X-linked agammaglobulinemia hospitalized for COVID-19 improved with convalescent plasma;Jin;J Allergy Clin Immunol In practice [Internet],2020
4. Velkury (remdesivir) EUA Letter of Approval. FDA O 2020. No Title [Internet]. Available from: https://www.fda.gov/media/137564/download.
5. Convalescent plasma therapy in patients with COVID-19;Yiğenoğlu;J Clin Apher Journal [Internet],2020
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献